AzTrials
AzTrials

Periodontal DiseasesUZFLAPSTUDNCT07283393

Observational Prospective Study on Resective and Regenerative Periodontal Therapy: Short & Longterm Follow-up

An observational study of Periodontal Diseases and Periodontitis, run by University Hospital, Ghent at 1 site in Belgium.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Periodontitis is a common inflammatory disease affecting approximately 40% of the Belgian population. The goal of this observational study is to learn about the treatment outcomes of surgical periodontal therapy in adults with periodontitis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Periodontal Diseases, Periodontitis
What is being tested?
Periodontal charting, peri-apical radiograph and low-dose small-field cone beam CT
How many people
30 participants
Where
1 siteBelgium
Study dates
1 Jan 2024to 31 Dec 2035
How long will I take part?
10 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients aged at least 18 years old have been treated for periodontitis through subgingival debridement. During re-evaluation, remaining pockets were found despite adequate oral hygiene. Depending on the anatomy of the defect, resective or regenerative surgery was performed. Patients were included if resective or regenerative periodontal surgery was performed < 6months ago and an informed consent was signed.

Who may be able to join

  • Min 18 years of age
  • Max 6 months since resective or regenerative periodontal surgery
  • Good general health

Who cannot join

  • Pregnancy and breastfeeding

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Ghent University Hospital

    Ghent, East-Flanders, 9000

Other trials in Belgium

About this study

Periodontitis is a common inflammatory disease affecting approximately 40% of the Belgian population.

The goal of this observational study is to learn about the treatment outcomes of surgical periodontal therapy in adults with periodontitis.

Read more

The main questions this study aims to answer are:

  • Does subsequent surgical intervention further improve periodontal health parameters?
  • Is there any significant difference between treatment outcomes of resective and regenerative periodontal surgery.

Participants will:

  • Undergo surgical periodontal treatment if residual pocket depth ≥6 mm persists despite good oral hygiene.

Study inclusion was performed after surgical treatment.

  • Be screened on various intervals. If there is any recurrent periodontitis, adequate treatment will be performed

In short term, pocket probing depth is our primary outcome and tooth survival is the outcome in the long term.

Secondary outcomes in short-term are bone level, mobility, bleeding on probing, tooth survival and cost-effectiveness.

Long-term outcomes (>5 years) are probing pocket depth, bone level, tooth sensitivity, mobility, bleeding on probing and cost-effectiveness.

Read the detailed description

Periodontitis is a common condition, affecting approximately 40% of the Belgian populations. The condition most common characteristics are bleeding of the gingiva and bone loss. Left untreated, this disease can lead to severe loss of maxillary or mandibulary bone. Treatment for primary stages of periodontitis don't always require surgical interventions; correction of oral hygiene and deep cleaning the teeth combined, if necessary, with extraction of irrational to treat elements under local anesthesia can be sufficient. Three months after initial treatment, at the re-evaluation, the depth of the tooth pockets, bleeding on probing, mobility and the amount of regression of the gums are reassessed. If the depth of the tooth pockets regressed insuffient, with a depth of at least six milimeters, eventhough the patients oral hygiene is acceptable, further surgical treatment is necessary. A patient is not able to clean these greater pockets.

Resective or regenerative surgery was performed, based on the bone morphology and the patients characteristics.

Inclusion of patients in this study was performed after surgical treatment. Research parameters will be evaluated at 6 months, 1 year, 3 years, 5 years, 7 and 10 years after surgery.

The main questions this study aims to answer are:

  • Does subsequent surgical intervention further improve periodontal health parameters?
  • Is there any significant difference between treatment outcomes of resective and regenerative periodontal surgery.

Primary outcomes are pocket probing depth in short-term and tooth survival in the long term.

Secondary outcomes in short-term include bone level, mobility, bleeding on probing, tooth survival and cost-effectiveness.

Long-term outcomes (>5 years) are probing pocket depth, bone level, tooth sensitivity, mobility, bleeding on probing and cost-effectiveness.

Being tested
Periodontal charting, peri-apical radiograph and low-dose small-field cone beam CT
Medical subject headings
Periodontal Diseases, Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Periodontal charting, peri-apical radiograph and low-dose small-field cone beam CTDiagnostic test

    Clinical measurements through periodontal charting, peri-apical radiography and cone-beam computed tomography. Clinical pictures of the mouth

Study groups in NCT07283393
Study groupRoleWhat they receive
Periodontitis patients actively treated with regenerative or resective surgery.Periodontitis patients actively treated with regenerative or resective surgery. The study commences only after the patient has undergone either a regenerative or resective periodontal surgery; the surgical procedure itself is not part of the investigation. The objective of the study is to monitor and compare both treatment modalities in the short and long term with respect to tooth survival, bone level, probing pocket depth, tooth sensitivity, mobility, bleeding on probing, and cost-effectiveness. The dental patient records will be reviewed to obtain available data from before and during the surgical procedure, including general patient information (age, sex, ASA classification, and medication), periodontal status, radiographic documentation, and clinical photographs.
Receives: Diagnostic Test: Periodontal charting, peri-apical radiograph and low-dose small-field cone beam CT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Probing depth

    Probing depth evolution in the short term

    Measured: At 6 months, 1 year, 3 years, 5 years, 7 years and 10 years of follow-up

  2. Tooth retention

    Survival of tooth in the long-term follow-up

    Measured: From enrollment to the end of the study, at 10 years of follow up

Secondary outcomes (3)
  1. Radiographic bone level

    A peri-apical radiograph will be taken at various recall appointments. Bone level will be measured using ImageJ software. Calibration will be performed using an orthodontic button, with known dimensions. Two measurements will be made; cemento-enamel junction to the bottom of the pocket and the infra-bony component (alveolar crest to bottom of pocket)

    Measured: 6 months, 3 years, 5 years, 7 years and 10 years

  2. Tooth mobility

    Mobility of the tooth is assessed using the Miller Classification (1958). Grade 1 is horizontal mobility <1mm, grade 2 is >2mm and grade 3 is horizontal + vertical mobility.

    Measured: At 6 months, 1 year, 3 years, 5, 7 and 10 years of follow-up.

  3. Bleeding on probing

    Bleeding on probing is assessed using a periodontal probe. A probe is inserted in the pocket and bleeding is noted dichotomously.

    Measured: At 6 months, 1 year, 3 years, 5, 7 and 10 years of follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2025
  2. Study start1 Jan 2024
  3. Primary completion31 Dec 2034 (estimated)
  4. Study completion31 Dec 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
30 participants (actual)
Target duration
10 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT07283393
Sponsor's protocol ID
ONZ-2023-0622
Acronym
UZFLAPSTUD
Status last verified
Dec 2025
First submitted
23 Nov 2025
Last updated
15 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Long-term follow up of study. No decision yet.

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases and Periodontitis, run by University Hospital, Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Probing depth (time frame: At 6 months, 1 year, 3 years, 5 years, 7 years and 10 years of follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in